Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Feb 7:67:e9.
doi: 10.1590/S1678-9946202567009. eCollection 2025.

Gas necrosis and sepsis due to recreational ketamine use

Affiliations
Case Reports

Gas necrosis and sepsis due to recreational ketamine use

Alexandre Sacchetti Bezerra et al. Rev Inst Med Trop Sao Paulo. .

Abstract

Although ketamine is an FDA-approved drug, its mechanism of action is not fully understood. Currently, there is an increase in its recreational use, causing irreparable social and physical damage. We report the case of a musician who developed sepsis due to gas necrosis in his arm after using veterinary ketamine purchased via the internet. Despite the amputation recommendation, it was possible to save the arm and preserve motor and sensory function. The scientific community, as well as the police and the government, must ponder the prescription, efficacy and safety of ketamine for medical treatments.

PubMed Disclaimer

Figures

Figure 1
Figure 1. (A) computed coronal tomography: presence of gas. Involvement of rotator cuff tendons, subacromial bursa and acromion; (B) computed tomography with axial analysis: gas in proximal humerus.
Figure 2
Figure 2. (A) deep infection with necrosis and an abscess; (B) Intra-operatory. Left arm with lesion measuring approximately 18,43 cm x 14,56 cm.
Figure 3
Figure 3. Post surgery. No motor deficits.

References

    1. Barbosa MG, Garcia GT, Sarin LM, Jackowski AP. Efficacy and safety of ketamine for the treatment of depressive symptoms in palliative care: a systematic review. Braz J Psychiatry. 2023;45:182–195. - PMC - PubMed
    1. Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018;70:621–660. - PMC - PubMed
    1. Andrade C. Ketamine for depression, 1: clinical summary of issues related to efficacy, adverse effects, and mechanism of action. J Clin Psychiatry. 2017;78:e415–e419. - PubMed
    1. Hess EM, Riggs LM, Michaelides M, Gould TD. Mechanisms of ketamine and its metabolites as antidepressants. 114892Biochem Pharmacol. 2022;197 - PMC - PubMed
    1. Feeney A, Papakostas GI. Pharmacotherapy: ketamine and esketamine. Psychiatr Clin North Am. 2023;46:277–290. - PubMed

Publication types

MeSH terms